MyC is a SaaS platform helping large organisations turn health from a compliance burden into an operational driver. It gives teams a unified, real-time view of workforce health, standardises medical operations across sites, and enables action before incidents escalate into absenteeism, risk, or cost.
The choice of Hi inov as lead investor for our Series A came naturally, driven by a strong strategic alignment between our fast-growing B2B SaaS platform and a fund recognised for its hands-on operational support of scale-ups. Beyond the financial investment, Hi inov brings proven expertise in commercial structuring and scaling, as well as a strong international culture rooted in the Dentressangle ecosystem—key to supporting MyC.doctor’s European and international expansion ambitions.
Don’t miss out on our latest content, and sign up for your newsletter !
